{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T00:53:05Z","timestamp":1791593585740,"version":"4.3.4"},"reference-count":61,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2010,2,28]],"date-time":"2010-02-28T00:00:00Z","timestamp":1267315200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nat Biotechnol"],"published-print":{"date-parts":[[2010,3]]},"DOI":"10.1038\/nbt.1608","type":"journal-article","created":{"date-parts":[[2010,2,28]],"date-time":"2010-02-28T13:11:48Z","timestamp":1267362708000},"page":"256-263","source":"Crossref","is-referenced-by-count":259,"title":["Harnessing chaperone-mediated autophagy for the selective degradation of mutant huntingtin protein"],"prefix":"10.1038","volume":"28","author":[{"given":"Peter O","family":"Bauer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anand","family":"Goswami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hon Kit","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Misako","family":"Okuno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaru","family":"Kurosawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mizuki","family":"Yamada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haruko","family":"Miyazaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gen","family":"Matsumoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshihiro","family":"Kino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshitaka","family":"Nagai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nobuyuki","family":"Nukina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2010,2,28]]},"reference":[{"key":"BFnbt1608_CR1","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1146\/annurev.neuro.23.1.217","volume":"23","author":"HY Zoghbi","year":"2000","unstructured":"Zoghbi, H.Y. & Orr, H.T. Glutamine repeats and neurodegeneration. Annu. Rev. Neurosci. 23, 217\u2013247 (2000).","journal-title":"Annu. Rev. Neurosci."},{"key":"BFnbt1608_CR2","doi-asserted-by":"publisher","first-page":"1990","DOI":"10.1126\/science.277.5334.1990","volume":"277","author":"M DiFiglia","year":"1997","unstructured":"DiFiglia, M. et al. Aggregation of huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain. Science 277, 1990\u20131993 (1997).","journal-title":"Science"},{"key":"BFnbt1608_CR3","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1016\/S0092-8674(00)80513-9","volume":"90","author":"SW Davies","year":"1997","unstructured":"Davies, S.W. et al. Formation of neuronal intranuclear inclusions underlies the neurological dysfunction in mice transgenic for the HD mutation. Cell 90, 537\u2013548 (1997).","journal-title":"Cell"},{"key":"BFnbt1608_CR4","doi-asserted-by":"publisher","first-page":"5596","DOI":"10.1073\/pnas.042681599","volume":"99","author":"MF Perutz","year":"2002","unstructured":"Perutz, M.F., Pope, B.J., Owen, D., Wanker, E.E. & Scherzinger, E. Aggregation of proteins with expanded glutamine and alanine repeats of the glutamine-rich and asparagine-rich domains of Sup35 and of the amyloid beta-peptide of amyloid plaques. Proc. Natl. Acad. Sci. USA 99, 5596\u20135600 (2002).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BFnbt1608_CR5","doi-asserted-by":"publisher","first-page":"34717","DOI":"10.1074\/jbc.M209852200","volume":"278","author":"M Tanaka","year":"2003","unstructured":"Tanaka, M. et al. Expansion of polyglutamine induces the formation of quasi-aggregate in the early stage of protein fibrillization. J. Biol. Chem. 278, 34717\u201334724 (2003).","journal-title":"J. Biol. Chem."},{"key":"BFnbt1608_CR6","doi-asserted-by":"publisher","first-page":"2238","DOI":"10.1126\/science.1072613","volume":"296","author":"AW Dunah","year":"2002","unstructured":"Dunah, A.W. et al. Sp1 and TAFII130 transcriptional activity disrupted in early Huntington's disease. Science 296, 2238\u20132243 (2002).","journal-title":"Science"},{"key":"BFnbt1608_CR7","doi-asserted-by":"publisher","first-page":"2423","DOI":"10.1126\/science.1056784","volume":"291","author":"FC Nucifora Jr.","year":"2001","unstructured":"Nucifora, F.C. Jr. et al. Interference by huntingtin and atrophin-1 with cbp-mediated transcription leading to cellular toxicity. Science 291, 2423\u20132428 (2001).","journal-title":"Science"},{"key":"BFnbt1608_CR8","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1038\/emboj.2008.23","volume":"27","author":"T Yamanaka","year":"2008","unstructured":"Yamanaka, T. et al. Mutant Huntingtin reduces HSP70 expression through the sequestration of NF-Y transcription factor. EMBO J. 27, 827\u2013839 (2008).","journal-title":"EMBO J."},{"key":"BFnbt1608_CR9","doi-asserted-by":"publisher","first-page":"1737","DOI":"10.1111\/j.1471-4159.2009.06302.x","volume":"110","author":"PO Bauer","year":"2009","unstructured":"Bauer, P.O. & Nukina, N. The pathogenic mechanisms of polyglutamine diseases and current therapeutic strategies. J. Neurochem. 110, 1737\u20131765 (2009).","journal-title":"J. Neurochem."},{"key":"BFnbt1608_CR10","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/S0092-8674(00)80623-6","volume":"101","author":"A Yamamoto","year":"2000","unstructured":"Yamamoto, A., Lucas, J.J. & Hen, R. Reversal of neuropathology and motor dysfunction in a conditional model of Huntington's disease. Cell 101, 57\u201366 (2000).","journal-title":"Cell"},{"key":"BFnbt1608_CR11","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/j.neures.2005.06.021","volume":"53","author":"YL Wang","year":"2005","unstructured":"Wang, Y.L. et al. Clinico-pathological rescue of a model mouse of Huntington's disease by siRNA. Neurosci. Res. 53, 241\u2013249 (2005).","journal-title":"Neurosci. Res."},{"key":"BFnbt1608_CR12","doi-asserted-by":"publisher","first-page":"17204","DOI":"10.1073\/pnas.0708285104","volume":"104","author":"M DiFiglia","year":"2007","unstructured":"DiFiglia, M. et al. Therapeutic silencing of mutant huntingtin with siRNA attenuates striatal and cortical neuropathology and behavioral deficits. Proc. Natl. Acad. Sci. USA. 104, 17204\u201317209 (2007).","journal-title":"Proc. Natl. Acad. Sci. USA."},{"key":"BFnbt1608_CR13","doi-asserted-by":"publisher","first-page":"5820","DOI":"10.1073\/pnas.0501507102","volume":"102","author":"SQ Harper","year":"2005","unstructured":"Harper, S.Q. et al. RNA interference improves motor and neuropathological abnormalities in a Huntington's disease mouse model. Proc. Natl. Acad. Sci. USA. 102, 5820\u20135825 (2005).","journal-title":"Proc. Natl. Acad. Sci. USA."},{"key":"BFnbt1608_CR14","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1016\/j.ymthe.2005.05.006","volume":"12","author":"E Rodriguez-Lebron","year":"2005","unstructured":"Rodriguez-Lebron, E., Denovan-Wright, E.M., Nash, K., Lewin, A.S. & Mandel, R.J. Intrastriatal rAAV-mediated delivery of anti-huntingtin shRNAs induces partial reversal of disease progression in R6\/1 Huntington's disease transgenic mice. Mol. Ther. 12, 618\u2013633 (2005).","journal-title":"Mol. Ther."},{"key":"BFnbt1608_CR15","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1038\/ng1362","volume":"36","author":"B Ravikumar","year":"2004","unstructured":"Ravikumar, B. et al. Inhibition of mTOR induces autophagy and reduces toxicity of polyglutamine expansions in fly and mouse models of Huntington disease. Nat. Genet. 36, 585\u2013595 (2004).","journal-title":"Nat. Genet."},{"key":"BFnbt1608_CR16","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1038\/nchembio883","volume":"3","author":"S Sarkar","year":"2007","unstructured":"Sarkar, S. et al. Small molecules enhance autophagy and reduce toxicity in Huntington's disease models. Nat. Chem. Biol. 3, 331\u2013338 (2007).","journal-title":"Nat. Chem. Biol."},{"key":"BFnbt1608_CR17","doi-asserted-by":"publisher","first-page":"3223","DOI":"10.1093\/hmg\/ddn218","volume":"17","author":"HK Wong","year":"2008","unstructured":"Wong, H.K. et al. Blocking acid-sensing ion channel 1 alleviates Huntington's disease pathology via an ubiquitin-proteasome system-dependent mechanism. Hum. Mol. Genet. 17, 3223\u20133235 (2008).","journal-title":"Hum. Mol. Genet."},{"key":"BFnbt1608_CR18","doi-asserted-by":"publisher","first-page":"13153","DOI":"10.1074\/jbc.M809229200","volume":"284","author":"PO Bauer","year":"2009","unstructured":"Bauer, P.O. et al. Inhibition of rho kinases enhances the degradation of mutant huntingtin. J. Biol. Chem. 284, 13153\u201313164 (2009).","journal-title":"J. Biol. Chem."},{"key":"BFnbt1608_CR19","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1247\/csf.27.421","volume":"27","author":"N Mizushima","year":"2002","unstructured":"Mizushima, N., Ohsumi, Y. & Yoshimori, T. Autophagosome formation in mammalian cells. Cell. Struct. Funct. 27, 421\u2013429 (2002).","journal-title":"Cell. Struct. Funct."},{"key":"BFnbt1608_CR20","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1126\/science.273.5274.501","volume":"273","author":"AM Cuervo","year":"1996","unstructured":"Cuervo, A.M. & Dice, J.F. A receptor for the selective uptake and degradation of proteins by lysosomes. Science 273, 501\u2013503 (1996).","journal-title":"Science"},{"key":"BFnbt1608_CR21","doi-asserted-by":"crossref","first-page":"2491","DOI":"10.1242\/jcs.114.13.2491","volume":"114","author":"FA Agarraberes","year":"2001","unstructured":"Agarraberes, F.A. & Dice, J.F. A molecular chaperone complex at the lysosomal membrane is required for protein translocation. J. Cell Sci. 114, 2491\u20132499 (2001).","journal-title":"J. Cell Sci."},{"key":"BFnbt1608_CR22","doi-asserted-by":"publisher","first-page":"10437","DOI":"10.1074\/jbc.275.14.10437","volume":"275","author":"Y Nagai","year":"2000","unstructured":"Nagai, Y. et al. Inhibition of polyglutamine protein aggregation and cell death by novel peptides identified by phage display screening. J. Biol. Chem. 275, 10437\u201310442 (2000).","journal-title":"J. Biol. Chem."},{"key":"BFnbt1608_CR23","doi-asserted-by":"publisher","first-page":"1292","DOI":"10.1126\/science.1101738","volume":"305","author":"AM Cuervo","year":"2004","unstructured":"Cuervo, A.M., Stefanis, L., Fredenburg, R., Lansbury, P.T. & Sulzer, D. Impaired degradation of mutant alpha-synuclein by chaperone-mediated autophagy. Science 305, 1292\u20131295 (2004).","journal-title":"Science"},{"key":"BFnbt1608_CR24","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1093\/emboj\/cdg002","volume":"22","author":"AM Cuervo","year":"2003","unstructured":"Cuervo, A.M., Mann, L., Bonten, E.J., d'Azzo, A. & Dice, J.F Cathepsin A regulates chaperone-mediated autophagy through cleavage of the lysosomal receptor. EMBO J. 22, 47\u201359 (2003).","journal-title":"EMBO J."},{"key":"BFnbt1608_CR25","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1093\/hmg\/ddg144","volume":"12","author":"Y Nagai","year":"2003","unstructured":"Nagai, Y. et al. Prevention of polyglutamine oligomerization and neurodegeneration by the peptide inhibitor QBP1 in Drosophila. Hum. Mol. Genet. 12, 1253\u20131259 (2003).","journal-title":"Hum. Mol. Genet."},{"key":"BFnbt1608_CR26","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1038\/nsmb1215","volume":"14","author":"Y Nagai","year":"2007","unstructured":"Nagai, Y. et al. A toxic monomeric conformer of the polyglutamine protein. Nat. Struct. Mol. Biol. 14, 332\u2013340 (2007).","journal-title":"Nat. Struct. Mol. Biol."},{"key":"BFnbt1608_CR27","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1038\/sj.embor.7400361","volume":"6","author":"H Tsutsui","year":"2005","unstructured":"Tsutsui, H., Karasawa, S., Shimizu, H., Nukina, N. & Miyawaki, A. Semi-rational engineering of a coral fluorescent protein into an efficient highlighter. EMBO Rep. 6, 233\u2013238 (2005).","journal-title":"EMBO Rep."},{"key":"BFnbt1608_CR28","doi-asserted-by":"publisher","first-page":"39","DOI":"10.4161\/auto.2229","volume":"2","author":"S Rodriguez-Enriquez","year":"2006","unstructured":"Rodriguez-Enriquez, S., Kim, I., Currin, R.T. & Lemasters, J.J. Tracker dyes to probe mitochondrial autophagy (mitophagy) in rat hepatocytes. Autophagy 2, 39\u201346 (2006).","journal-title":"Autophagy"},{"key":"BFnbt1608_CR29","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1111\/j.1471-4159.2007.05032.x","volume":"104","author":"A Weiss","year":"2008","unstructured":"Weiss, A. et al. Sensitive biochemical aggregate detection reveals aggregation onset before symptom development in cellular and murine models of Huntington's disease. J. Neurochem. 104, 846\u2013858 (2008).","journal-title":"J. Neurochem."},{"key":"BFnbt1608_CR30","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1111\/j.1471-4159.2005.03035.x","volume":"93","author":"S Kotliarova","year":"2005","unstructured":"Kotliarova, S. et al. Decreased expression of hypothalamic neuropeptides in Huntington disease transgenic mice with expanded polyglutamine-EGFP fluorescent aggregates. J. Neurochem. 93, 641\u2013653 (2005).","journal-title":"J. Neurochem."},{"key":"BFnbt1608_CR31","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1038\/nrn1386","volume":"5","author":"MF Beal","year":"2004","unstructured":"Beal, M.F. & Ferrante, R.J. Experimental therapeutics in transgenic mouse models of Huntington's disease. Nat. Rev. Neurosci. 5, 373\u2013384 (2004).","journal-title":"Nat. Rev. Neurosci."},{"key":"BFnbt1608_CR32","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1602\/neurorx.2.3.447","volume":"2","author":"JY Li","year":"2005","unstructured":"Li, J.Y., Popovic, N. & Brundin, P. The use of the R6 transgenic mouse models of Huntington's Disease in attempts to develop novel therapeutic strategies. NeuroRx 2, 447\u2013464 (2005).","journal-title":"NeuroRx"},{"key":"BFnbt1608_CR33","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1038\/nm985","volume":"10","author":"M Tanaka","year":"2004","unstructured":"Tanaka, M. et al. Trehalose alleviates polyglutamine-mediated pathology in a mouse model of Huntington disease. Nat. Med. 10, 148\u2013154 (2004).","journal-title":"Nat. Med."},{"key":"BFnbt1608_CR34","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1038\/nature01301","volume":"421","author":"I Sanchez","year":"2003","unstructured":"Sanchez, I., Mahlke, C. & Yuan, J. Pivotal role of oligomerization in expanded polyglutamine neurodegenerative disorders. Nature 421, 373\u2013379 (2003).","journal-title":"Nature"},{"key":"BFnbt1608_CR35","doi-asserted-by":"publisher","first-page":"7388","DOI":"10.1073\/pnas.96.13.7388","volume":"96","author":"MV Karpuj","year":"1999","unstructured":"Karpuj, M.V. et al. Transglutaminase aggregates huntingtin into nonamyloidogenic polymers, and its enzymatic activity increases in Huntington's disease brain nuclei. Proc. Natl. Acad. Sci. USA 96, 7388\u20137393 (1999).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BFnbt1608_CR36","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1038\/nm0202-143","volume":"8","author":"MV Karpuj","year":"2002","unstructured":"Karpuj, M.V. et al. Prolonged survival and decreased abnormal movements in transgenic model of Huntington disease, with administration of the transglutaminase inhibitor cystamine. Nat. Med. 8, 143\u2013149 (2002).","journal-title":"Nat. Med."},{"key":"BFnbt1608_CR37","doi-asserted-by":"publisher","first-page":"8942","DOI":"10.1523\/JNEUROSCI.22-20-08942.2002","volume":"22","author":"A Dedeoglu","year":"2002","unstructured":"Dedeoglu, A. et al. Therapeutic effects of cystamine in a murine model of Huntington's disease. J. Neurosci. 22, 8942\u20138950 (2002).","journal-title":"J. Neurosci."},{"key":"BFnbt1608_CR38","doi-asserted-by":"publisher","first-page":"9418","DOI":"10.1523\/JNEUROSCI.23-28-09418.2003","volume":"23","author":"RJ Ferrante","year":"2003","unstructured":"Ferrante, R.J. et al. Histone deacetylase inhibition by sodium butyrate chemotherapy ameliorates the neurodegenerative phenotype in Huntington's disease mice. J. Neurosci. 23, 9418\u20139427 (2003).","journal-title":"J. Neurosci."},{"key":"BFnbt1608_CR39","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1016\/j.bbadis.2006.03.004","volume":"1762","author":"KM Smith","year":"2006","unstructured":"Smith, K.M. et al. Dose ranging and efficacy study of high-dose coenzyme Q10 formulations in Huntington's disease mice. Biochim. Biophys. Acta 1762, 616\u2013626 (2006).","journal-title":"Biochim. Biophys. Acta"},{"key":"BFnbt1608_CR40","doi-asserted-by":"publisher","first-page":"11840","DOI":"10.1073\/pnas.0502177102","volume":"102","author":"T Nguyen","year":"2005","unstructured":"Nguyen, T., Hamby, A. & Massa, S.M. Clioquinol down-regulates mutant huntingtin expression in vitro and mitigates pathology in a Huntington's disease mouse model. Proc. Natl. Acad. Sci. USA 102, 11840\u201311845 (2005).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BFnbt1608_CR41","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1038\/20446","volume":"399","author":"VO Ona","year":"1999","unstructured":"Ona, V.O. et al. Inhibition of caspase-1 slows disease progression in a mouse model of Huntington's disease. Nature 399, 263\u2013267 (1999).","journal-title":"Nature"},{"key":"BFnbt1608_CR42","doi-asserted-by":"publisher","first-page":"18189","DOI":"10.1073\/pnas.0506375102","volume":"102","author":"K Jin","year":"2005","unstructured":"Jin, K. et al. FGF-2 promotes neurogenesis and neuroprotection and prolongs survival in a transgenic mouse model of Huntington's disease. Proc. Natl. Acad. Sci. USA 102, 18189\u201318194 (2005).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BFnbt1608_CR43","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.expneurol.2007.10.015","volume":"210","author":"Q Peng","year":"2008","unstructured":"Peng, Q. et al. The antidepressant sertraline improves the phenotype, promotes neurogenesis and increases BDNF levels in the R6\/2 Huntington's disease mouse model. Exp. Neurol. 210, 154\u2013163 (2008).","journal-title":"Exp. Neurol."},{"key":"BFnbt1608_CR44","doi-asserted-by":"publisher","first-page":"10335","DOI":"10.1523\/JNEUROSCI.2599-04.2004","volume":"24","author":"RJ Ferrante","year":"2004","unstructured":"Ferrante, R.J. et al. Chemotherapy for the brain: the antitumor antibiotic mithramycin prolongs survival in a mouse model of Huntington's disease. J. Neurosci. 24, 10335\u201310342 (2004).","journal-title":"J. Neurosci."},{"key":"BFnbt1608_CR45","doi-asserted-by":"publisher","first-page":"19176","DOI":"10.1073\/pnas.0606373103","volume":"103","author":"H Ryu","year":"2006","unstructured":"Ryu, H. et al. ESET\/SETDB1 gene expression and histone H3 (K9) trimethylation in Huntington's disease. Proc. Natl. Acad. Sci. USA 103, 19176\u201319181 (2006).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BFnbt1608_CR46","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.neulet.2008.06.015","volume":"449","author":"HA Popiel","year":"2009","unstructured":"Popiel, H.A., Nagai, Y., Fujikake, N. & Toda, T. Delivery of the aggregate inhibitor peptide QBP1 into the mouse brain using PTDs and its therapeutic effect on polyglutamine disease mice. Neurosci. Lett. 449, 87\u201392 (2009).","journal-title":"Neurosci. Lett."},{"key":"BFnbt1608_CR47","doi-asserted-by":"publisher","first-page":"13589","DOI":"10.1523\/JNEUROSCI.4286-09.2009","volume":"29","author":"AL Southwell","year":"2009","unstructured":"Southwell, A.L., Ko, J. & Patterson, P.H. Intrabody gene therapy ameliorates motor, cognitive, and neuropathological symptoms in multiple mouse models of Huntington's disease. J. Neurosci. 29, 13589\u201313602 (2009).","journal-title":"J. Neurosci."},{"key":"BFnbt1608_CR48","doi-asserted-by":"publisher","first-page":"5820","DOI":"10.1073\/pnas.0501507102","volume":"102","author":"SQ Harper","year":"2005","unstructured":"Harper, S.Q. et al. RNA interference improves motor and neuropathological abnormalities in a Huntington's disease mouse model. Proc. Natl. Acad. Sci. USA 102, 5820\u20135825 (2005).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BFnbt1608_CR49","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1016\/j.ymthe.2005.05.006","volume":"12","author":"E Rodriguez-Lebron","year":"2005","unstructured":"Rodriguez-Lebron, E., Denovan-Wright, E.M., Nash, K., Lewin, A.S. & Mandel, R.J. Intrastriatal rAAV-mediated delivery of anti-huntingtin shRNAs induces partial reversal of disease progression in R6\/1 Huntington's disease transgenic mice. Mol. Ther. 12, 618\u2013633 (2005).","journal-title":"Mol. Ther."},{"key":"BFnbt1608_CR50","doi-asserted-by":"publisher","first-page":"17204","DOI":"10.1073\/pnas.0708285104","volume":"104","author":"M DiFiglia","year":"2007","unstructured":"DiFiglia, M. et al. Therapeutic silencing of mutant huntingtin with siRNA attenuates striatal and cortical neuropathology and behavioral deficits. Proc. Natl. Acad. Sci. USA 104, 17204\u201317209 (2007).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BFnbt1608_CR51","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1089\/hum.2006.160","volume":"18","author":"B Huang","year":"2007","unstructured":"Huang, B. et al. High-capacity adenoviral vector-mediated reduction of huntingtin aggregate load in vitro and in vivo. Hum. Gene Ther. 18, 303\u2013311 (2007).","journal-title":"Hum. Gene Ther."},{"key":"BFnbt1608_CR52","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1111\/j.1471-4159.2008.05734.x","volume":"108","author":"Y Zhang","year":"2009","unstructured":"Zhang, Y., Engelman, J. & Friedlander, R.M. Allele-specific silencing of mutant Huntington's disease gene. J. Neurochem. 108, 82\u201390 (2009).","journal-title":"J. Neurochem."},{"key":"BFnbt1608_CR53","doi-asserted-by":"publisher","first-page":"2889","DOI":"10.1172\/JCI31778","volume":"117","author":"SR Cho","year":"2007","unstructured":"Cho, S.R. et al. Induction of neostriatal neurogenesis slows disease progression in a transgenic murine model of Huntington disease. J. Clin. Invest. 117, 2889\u20132902 (2007).","journal-title":"J. Clin. Invest."},{"key":"BFnbt1608_CR54","doi-asserted-by":"publisher","first-page":"9013","DOI":"10.1523\/JNEUROSCI.2747-08.2008","volume":"28","author":"AL Southwell","year":"2008","unstructured":"Southwell, A.L. et al. Intrabodies binding the proline-rich domains of mutant huntingtin increase its turnover and reduce neurotoxicity. J. Neurosci. 28, 9013\u20139020 (2008).","journal-title":"J. Neurosci."},{"key":"BFnbt1608_CR55","doi-asserted-by":"publisher","first-page":"1132","DOI":"10.1016\/j.jmb.2007.02.089","volume":"368","author":"S Emadi","year":"2007","unstructured":"Emadi, S., Barkhordarian, H., Wang, M.S., Schulz, P. & Sierks, M.R. Isolation of a human single chain antibody fragment against oligomeric alpha-synuclein that inhibits aggregation and prevents alpha-synuclein-induced toxicity. J. Mol. Biol. 368, 1132\u20131144 (2007).","journal-title":"J. Mol. Biol."},{"key":"BFnbt1608_CR56","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/j.jmb.2007.11.096","volume":"377","author":"SM Lynch","year":"2008","unstructured":"Lynch, S.M., Zhou, C. & Messer, A. An scFv intrabody against the nonamyloid component of alpha-synuclein reduces intracellular aggregation and toxicity. J. Mol. Biol. 377, 136\u2013147 (2008).","journal-title":"J. Mol. Biol."},{"key":"BFnbt1608_CR57","doi-asserted-by":"publisher","first-page":"2435","DOI":"10.1097\/00001756-199908200-00001","volume":"10","author":"GH Wang","year":"1999","unstructured":"Wang, G.H. et al. Caspase activation during apoptotic cell death induced by expanded polyglutamine in N2a cells. Neuroreport 10, 2435\u20132438 (1999).","journal-title":"Neuroreport"},{"key":"BFnbt1608_CR58","doi-asserted-by":"publisher","first-page":"1795","DOI":"10.1093\/hmg\/9.12.1795","volume":"9","author":"GH Wang","year":"2000","unstructured":"Wang, G.H., Sawai, N., Kotliarova, S., Kanazawa, I. & Nukina, N. Ataxin-3, the MJD1 gene product, interacts with the two human homologs of yeast DNA repair protein RAD23, HHR23A and HHR23B. Hum. Mol. Genet. 9, 1795\u20131803 (2000).","journal-title":"Hum. Mol. Genet."},{"key":"BFnbt1608_CR59","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/S0304-3940(99)00758-2","volume":"275","author":"MF Peters","year":"1999","unstructured":"Peters, M.F. & Ross, C.A. Preparation of human cDNas encoding expanded polyglutamine repeats. Neurosci. Lett. 275, 129\u2013132 (1999).","journal-title":"Neurosci. Lett."},{"key":"BFnbt1608_CR60","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1046\/j.1471-4159.2003.02002.x","volume":"87","author":"EA Zemskov","year":"2003","unstructured":"Zemskov, E.A. et al. Pro-apoptotic protein kinase C delta is associated with intranuclear inclusions in a transgenic model of Huntington's disease. J. Neurochem. 87, 395\u2013406 (2003).","journal-title":"J. Neurochem."},{"key":"BFnbt1608_CR61","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/0003-9861(87)90539-X","volume":"257","author":"EA Madden","year":"1987","unstructured":"Madden, E.A., Wirt, J.B. & Storrie, B. Purification and characterization of lysosomes from Chinese hamster ovary cells. Arch. Biochem. Biophys. 257, 27\u201338 (1987).","journal-title":"Arch. Biochem. Biophys."}],"container-title":["Nature Biotechnology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/nbt.1608.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nbt.1608","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nbt.1608.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,24]],"date-time":"2024-03-24T09:55:01Z","timestamp":1711274101000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/nbt.1608"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,2,28]]},"references-count":61,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2010,3]]}},"alternative-id":["BFnbt1608"],"URL":"https:\/\/doi.org\/10.1038\/nbt.1608","relation":{},"ISSN":["1087-0156","1546-1696"],"issn-type":[{"value":"1087-0156","type":"print"},{"value":"1546-1696","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,2,28]]}}}